Bioengineered probiotics to control SARS-CoV-2 infection
The outbreak of 2019 novel corona virus disease (COVID-19) is now a global public health crisis and declared as a pandemic. Several recent studies suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein binds to human angiotensin-converting enzyme 2 (ACE2). The inform...
Main Authors: | Shantibhusan Senapati, Jayalaxmi Dash, Manisha Sethi, Subhankar Chakraborty |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2020-05-01
|
Series: | Research Ideas and Outcomes |
Subjects: | |
Online Access: | https://riojournal.com/article/54802/download/pdf/ |
Similar Items
-
Comparison of Selected Characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63
by: Darina Bačenková, et al.
Published: (2021-02-01) -
SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
by: Thankamani Karthika, et al.
Published: (2021-07-01) -
Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
by: Sai Priya Anand, et al.
Published: (2020-09-01) -
Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
by: Ren Yang, et al.
Published: (2020-08-01) -
Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2)
by: Nosheen Masood, et al.
Published: (2020-08-01)